Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 20, 2025 09:54 ET | Source: Research and Markets

DNA Cancer Vaccine Clinical Trials & Market Opportunity Outlook 2026 | First Commercial Approval of DNA Cancer Vaccine Anticipated by 2030

Dublin, Oct. 20, 2025 (GLOBE NEWSWIRE) -- The "DNA Cancer Vaccine Clinical Trials, Development Technology Platforms & Market Opportunity Outlook 2026" report has been added to ...
September 10, 2025 04:06 ET | Source: Research and Markets

Peptide Cancer Vaccine Market Clinical Trials Insight Report: Over 50 Peptide Cancer Vaccines in Clinical Trials

Dublin, Sept. 10, 2025 (GLOBE NEWSWIRE) -- The "Peptide Cancer Vaccine Market Opportunity, Technology Platforms & Clinical Trials Insight 2030" report has been added to ResearchAndMarkets.com's...
September 03, 2025 05:08 ET | Source: Research and Markets

Cancer Vaccines Market Worth $14.15 Billion by 2030: Emerging Trends & Competitive Strategies Shaping the Industry

Dublin, Sept. 03, 2025 (GLOBE NEWSWIRE) -- The "Cancer Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" has been added to ResearchAndMarkets.com's...
August 12, 2025 09:29 ET | Source: Research and Markets

Neoantigen Cancer Vaccine Market Analysis 2025-2030: Emergence of mRNA-based Neoantigen Vaccine Platforms Driving Growth

Dublin, Aug. 12, 2025 (GLOBE NEWSWIRE) -- The "Neoantigen Cancer Vaccine Market by Neoantigen Type (Personalized Neoantigens, Shared Neoantigens), Therapeutic Target (Immune Checkpoint Blockade,...
August 05, 2025 04:03 ET | Source: Research and Markets

Cancer Vaccine Research Report 2025-2035 | Market Accelerates with Key Players Like Merck and Moderna, Backed by Pharma-Biotech Collaborations and Academic Partnerships

Dublin, Aug. 05, 2025 (GLOBE NEWSWIRE) -- The "Cancer Vaccine Market - A Global and Regional Analysis: Focus on Vaccine Type, Technology Type, and Region - Analysis and Forecast, 2025-2035" report...
July 30, 2025 04:31 ET | Source: Research and Markets

Cancer Vaccine Market Research Service Featuring the Top 5 Developers and Pipeline Activities - OncoTherapy Science, Inovio, BioNTech, Theravectys, and GlaxoSmithKline

Dublin, July 30, 2025 (GLOBE NEWSWIRE) -- The "Unlocking Opportunity: Dominate the Cancer Vaccine Market with Confidence" directory has been added to ResearchAndMarkets.com's offering. The world...
July 07, 2025 07:17 ET | Source: Research and Markets

mRNA Cancer Vaccines Clinical Trials & Future Market Outlook 2025: Personalized mRNA Cancer Vaccines Revolutionize Oncology with Neoantigen-Driven Immunotherapy

Dublin, July 07, 2025 (GLOBE NEWSWIRE) -- The "mRNA Cancer Vaccines Clinical Trials, Market Trends By Indication, Development Priority Status & Market Opportunity Insight 2025" drug pipelines...
June 27, 2025 09:35 ET | Source: Research and Markets

Cancer Vaccine (Preventative, Therapeutic) Market Research 2025 with Analyst Recommendations-Leveraging AI and Bioinformatics for Precision Development / Pursue Fast-Track and Orphan Drug Designations

Dublin, June 27, 2025 (GLOBE NEWSWIRE) -- The "Cancer Vaccine Market (2025 Edition): Analysis By Type (Preventative, Therapeutic), By Technology Type, By Region, By Country: Market Insights and...
June 19, 2025 06:55 ET | Source: Research and Markets

Human Papillomavirus (HPV) Vaccines Strategic Business Research Report 2024-2025 & 2030 - Rising Global Awareness of HPV-Linked Cervical and Oropharyngeal Cancers Drives Preventive Vaccination Uptake

Dublin, June 19, 2025 (GLOBE NEWSWIRE) -- The "Human Papillomavirus (HPV) Vaccines - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market...
June 13, 2025 09:48 ET | Source: Research and Markets

Neoantigen Cancer Vaccines Industry Analysis Report 2025 with Tariff-Adjusted Forecasts and Analytics to 2030

Dublin, June 13, 2025 (GLOBE NEWSWIRE) -- The "Neoantigen Cancer Vaccines - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Neoantigen...